Overview

Kensey Nash Corporation (KNC) is a leader in developing, manufacturing and processing proprietary resorbable biomaterial products, incorporating our collagen technology and synthetic polymers. In the past year, KNC manufactured and sold over 4 million resorbable device units representing approximately 220 commercialized devices to strategic partners and customers, which are market leaders in their segments. One of our devices is inserted in a human body on average every 10 minutes. KNC provides an extensive range of products in multiple medical markets, including the orthopedic, sports medicine, spine, endovascular and general surgery markets. We sell our products through strategic partners and do not sell directly to the end user. KNC is based in Exton, Pennsylvania with approximately 300 employees.

Stock Listing

Kensey Nash Corporation’s common stock is traded on the NASDAQ Exchange under the symbol KNSY. The Company currently does not offer direct purchase of shares.

Transfer Agent and Registrar

Computershare Trust Company, Inc. is the transfer agent and registrar for the Kensey Nash Corporation. Stockholders of record with questions about your shares, lost or stolen certificates or notification of address change should contact:

Computershare Trust Company, Inc.
350 Indiana Street, Suite 800, Golden , CO 80401
Telephone: 303.262.0600 - Internet: www.computershare.com

Independent Accountants

Deloitte & Touche, LLP
Philadelphia, Pennsylvania

Investor Relations Contact

Kensey Nash Corporation
Attn: Investor Relations
735 Pennsylvania Drive
Exton, PA 19341
Telephone: 800.524.1984 - Fax: 484-713-2900

Click here to request an investor's information packet.